David Steensma, MD, FACP is an associate professor at Harvard Medical School and faculty member in the leukemia program at Dana-Farber Cancer Institute and Brigham and Women’s Hospital in Boston, Massachusetts. He treats patients with myelodysplastic syndromes (MDS), leukemia, and other bone marrow failure diseases. His research focuses on clinical trials and new drug development and collaborative efforts related to MDS molecular genetics.